Table 7.
Natural Source | Compound | HCV | Target | CC50 (µg/mL) |
EC50-IC50 (µg/mL) | SI or TI | Reference |
---|---|---|---|---|---|---|---|
Trichilia dregeana | Root extract | HCV | Inhibition of viral entry | 16.6 | 37 | [94] | |
Detarium
microcarpum |
Stem bark extract | 1.42 | 211 | ||||
Phragmanthera
capitata |
Leave extract | 13.17 | |||||
Bupleurum kaoi | Saikosaponin B2 | 740.4 ± 28.35 µM | 16.13 ± 2.41 µM | 45.9 | [95] | ||
Bupleurum kaoi | Methanolic extract | 16.82 ± 1.89 | 215.4 ± 10.7 | 12.8 | |||
Anthocyanidin | Delphinidin | 3.7 ± 0.8 μM | [96] | ||||
Alloeocomatella polycladia | Ethyl acetate- soluble fraction |
Suppression of the helicase activity of HCV NS3 |
11.7 ± 0.7 | [97] | |||
Fusarium equiseti | Crude extracts | Inhibition of HCV NS3/4A protease | 19–77 µM | [98] | |||
Eclipta alba | Aqueous extract | Inhibition of HCV NS5B replicase activity |
11 | [99] | |||
Taraxacum officinale | Flavonoids | [100] | |||||
Swietenia macrophylla | 3-hydroxy caruilignan C | Reduction of HCV protein and HCV- RNA levels |
10.5 ± 1.2μM | [101] | |||
Entada africana | Methylene chloride-methanol (MCM) stem bark crude extract |
Broad antiviral activity | 453 ± 0.00117 | [102] | |||
Grape seed | Phenolic compounds |
Suppression of HCV- induced Cox-2 |
7.5 ± 0.3 | [104] | |||
Flavanone | Naringenin | Release/Assembly | 109 μM | [107] |
CC50: Half maximal cytotoxic concentration; EC50-IC50: Half maximal inhibitory concentration; SI: Selectivity index = CC50/IC50.